ImageneBio, Inc.
IMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001835579
In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in ImageneBio, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +15 vs. Q1 2021
- Shares held
- 21.1M
- +1.75M (+9.1%) vs. Q1 2021
- Total value
- $293.2M
- −$245.3M (−45.6%) vs. Q1 2021
- New holders
- 22
- 8 more added
- Sold out
- 7
- 3 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $36.8M |
| Q1 2026 | 39 | $26.8M |
| Q4 2025 | 41 | $32.9M |
| Q3 2025 | 33 | $38.3M |
| Q2 2025 | 41 | $42.6M |
| Q1 2025 | 46 | $41.9M |
| Q4 2024 | 53 | $52.0M |
| Q3 2024 | 57 | $49.1M |
| Q2 2024 | 70 | $47.9M |
| Q1 2024 | 57 | $42.7M |
| Q4 2023 | 54 | $63.8M |
| Q3 2023 | 58 | $141.6M |
| Q2 2023 | 52 | $204.7M |
| Q1 2023 | 39 | $86.2M |
| Q4 2022 | 34 | $69.9M |
| Q3 2022 | 42 | $93.2M |
| Q2 2022 | 46 | $118.7M |
| Q1 2022 | 48 | $167.8M |
| Q4 2021 | 49 | $343.6M |
| Q3 2021 | 39 | $271.8M |
| Q2 2021 | 42 | $293.2M |
| Q1 2021 | 27 | $538.5M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding ImageneBio, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 364 | $5.00K | 0.00% | +364 | New |
| Citigroup Inc | 430 | $6.00K | 0.00% | +430 | New |
| Royal Bank of Canada | 621 | $9.00K | 0.00% | +621 | New |
| Legal & General Group Plc | 723 | $10.0K | 0.00% | +723 | New |
| Ameritas Investment Partners, Inc. | 711 | $10.0K | 0.00% | +711 | New |
| Tower Research Capital LLC (TRC) | 1,228 | $17.0K | 0.00% | +1,228 | New |
| STRS Ohio | 2,100 | $29.0K | 0.00% | +2,100 | New |
| JPMorgan Chase & Co | 3,481 | $49.0K | 0.00% | +3,481 | New |
| Wells Fargo & Company | 4,207 | $59.0K | 0.00% | +4,207 | New |
| Bank of America Corp | 4,298 | $60.0K | 0.00% | +4,298 | New |
| American International Group, Inc. | 5,081 | $71.0K | 0.00% | +5,081 | New |
| Deutsche Bank AG | 5,384 | $76.0K | 0.00% | +5,384 | New |
| New York State Common Retirement Fund | 7,700 | $108.0K | 0.00% | +7,700 | New |
| D. E. Shaw & Co., Inc. | 11,984 | $168.0K | 0.00% | +11,984 | New |
| California State Teachers Retirement System | 12,523 | $176.0K | 0.00% | +12,523 | New |
| Bank of New York Mellon Corp | 18,073 | $254.0K | 0.00% | +18,073 | New |
| Charles Schwab Investment Management Inc | 22,769 | $320.0K | 0.00% | +22,769 | New |
| Pinz Capital Management, LP | 25,390 | $356.0K | 0.11% | +25,390 | New |
| Nuveen Asset Management, LLC | 27,055 | $379.0K | 0.00% | +27,055 | New |
| Millennium Management LLC | 61,561 | $864.0K | 0.00% | −8,948−12.7% | Reduced |
| State Street Corp | 76,452 | $1.07M | 0.00% | +76,452 | New |
| Northern Trust Corp | 85,062 | $1.19M | 0.00% | +85,062 | New |
| Victory Capital Management Inc | 92,180 | $1.29M | 0.00% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 100,000 | $1.40M | 0.02% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 100,000 | $1.41M | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 117,250 | $1.65M | 0.00% | +117,250 | New |
| Logos Global Management LP | 299,853 | $4.21M | 0.36% | −120,000−28.6% | Reduced |
| Credit Suisse AG | 302,619 | $4.25M | 0.00% | +278,197+1,139.1% | Added |
| Vanguard Group Inc | 328,612 | $4.61M | 0.00% | +268,612+447.7% | Added |
| Nantahala Capital Management, LLC | 349,660 | $4.91M | 0.27% | +24,660+7.6% | Added |
| HealthCor Management, L.P. | 377,551 | $5.30M | 0.22% | +36,339+10.6% | Added |
| Octagon Capital Advisors LP | 400,000 | $5.62M | 1.16% | 00.0% | Unchanged |
| BlackRock Inc. | 449,738 | $6.31M | 0.00% | +362,718+416.8% | Added |
| Ra Capital Management, L.P. | 750,000 | $10.5M | 0.17% | 00.0% | Unchanged |
| CHI Advisors LLC | 814,756 | $11.4M | 2.66% | 00.0% | Unchanged |
| Farallon Capital Management, L.L.C. | 1,117,349 | $15.7M | 0.08% | −232,164−17.2% | Reduced |
| Artal Group S.A. | 1,549,513 | $21.8M | 0.50% | 00.0% | Unchanged |
| BVF Inc | 1,767,399 | $24.8M | 0.93% | +167,741+10.5% | Added |
| Citadel Advisors LLC | 2,156,621 | $29.5M | 0.03% | +103,553+5.0% | Added |
| Omega Fund Management, LLC | 2,249,123 | $31.6M | 3.57% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 2,933,941 | $41.2M | 0.42% | 00.0% | Unchanged |
| FMR LLC | 4,431,657 | $60.5M | 0.00% | +654,019+17.3% | Added |
| Woodline Partners LP | 0 | $0 | 0.00% | −113,652−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −39,100−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −28,738−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −13,759−100.0% | Sold out |
| Hound Partners, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −9,805−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −970−100.0% | Sold out |